Double blind, randomised, parallel group, placebo controlled clinical trial of S(+)-ibuprofen effects on TxB2 [thromboxane B2] concentrations and platelet aggregation in aspirin-treated healthy adult volunteers.

Trial Profile

Double blind, randomised, parallel group, placebo controlled clinical trial of S(+)-ibuprofen effects on TxB2 [thromboxane B2] concentrations and platelet aggregation in aspirin-treated healthy adult volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Dexibuprofen (Primary)
  • Indications Pain
  • Focus Pharmacodynamics
  • Sponsors Gebro Pharma GmbH
  • Most Recent Events

    • 10 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top